Tandem Diabetes Care Inc. [TNDM] stock is up 4.59 while the S&P 500 has fallen -0.63% on Tuesday, 10/13/20. While at the time of this article, TNDM ATR is sitting at 4.21, with the beta value at 0.44. This stock’s volatility for the past week remained at 3.78%, while it was 3.49% for the past 30-day period. TNDM has risen $5.34 from the previous closing price of $116.41 on volume of 1.8 million shares.
On 8, October 2020, Tandem Diabetes Care to Announce Third Quarter 2020 Financial Results on November 5, 2020. According to news published on Yahoo Finance, Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2020 results after the financial markets close on Thursday, November 5, 2020. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2020 financial and operating results.
Analyst Birdseye View:
The most recent analyst activity for Tandem Diabetes Care Inc. [NASDAQ:TNDM] stock was on July 31, 2020, when it was Upgrade with a Buy rating from Guggenheim. Before that, on August 20, 2020, Wells Fargo Recapitulated an Overweight rating and elevated its amount target to $120. On July 06, 2020, Citigroup Upgrade a Buy rating and boosted its price target on this stock to $120. On June 18, 2020, Raymond James Reiterated an Outperform rating and increased its price target from $88 to $95. On April 24, 2020, SVB Leerink Downgrade a Mkt perform rating. On March 23, 2020, Guggenheim Downgrade a Neutral rating. On March 05, 2020, Citigroup Initiated a Neutral rating and boosted its target amount on this stock to $89. Raymond James elevated its amount target by recapitulating a higher weight for this stock.
In the past 52 weeks of trading, this stock has oscillated between a low of $43.69 and a peak of $118.80. Right now, according to Wall Street analyst the average 12-month amount target is $120.13. At the most recent market close, shares of Tandem Diabetes Care Inc. [NASDAQ:TNDM] were valued at $121.75. According to the average price forecast, investors can expect a potential return of -0.39%.
Tandem Diabetes Care Inc. [NASDAQ:TNDM] most recently reported quarterly sales of 109.24 billion, which represented growth of 17.00%. This publicly-traded organization’s revenue is $347,368 per employee, while its income is -$23,733 per employee. This company’s Gross Margin is currently 52.60%, its Operating Margin is -7.20%, its Pretax Margin is -6.79, and its Net Margin is -6.83. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -9.30, -15.17, -9.65 and -14.55 respectively.
If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 9.46 and the whole liability to whole assets at 6.25. It shows enduring liability to the whole principal at 6.53 and enduring liability to assets at 0.04 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 117.50 points at 1st support level, the second support level is making up to 113.25. But as of 1st resistance point, this stock is sitting at 124.87 and at 127.99 for 2nd resistance point.
Tandem Diabetes Care Inc. [TNDM] reported its earnings at -$0.45 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.24/share signifying the difference of -0.21 and -87.50% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were -$0.25 calling estimates for -$0.17/share with the difference of -0.08 depicting the surprise of -47.10%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Tandem Diabetes Care Inc. [NASDAQ:TNDM] is 4.70. Likewise, the Quick ratio is also the same, showing Cash ratio at 1.78. Now if looking for a valuation of this stock’s amount to sales ratio it’s 9.63 and it’s amount to book ratio is 18.16.
The most recent insider trade was by HANSEN BRIAN B, EVP & CHIEF COMMERCIAL OFFICER, and it was the sale of 15000.0 shares on Oct 07. HANSEN BRIAN B, the EVP & CHIEF COMMERCIAL OFFICER, completed a sale of 4489.0 shares on Sep 29. On Sep 16, HANSEN BRIAN B, EVP & CHIEF COMMERCIAL OFFICER, completed a sale of 10525.0 shares.